Show simple item record

dc.contributor.authorAmadid, Hanan
dc.contributor.authorJohansen, Nanna B
dc.contributor.authorBjerregaard, Anne-Louise
dc.contributor.authorBrage, Soren
dc.contributor.authorFærch, Kristine
dc.contributor.authorLauritzen, Torsten
dc.contributor.authorWitte, Daniel R
dc.contributor.authorSandbæk, Annelli
dc.contributor.authorJørgensen, Marit E
dc.contributor.authorVistisen, Dorte
dc.date.accessioned2018-11-17T00:31:15Z
dc.date.available2018-11-17T00:31:15Z
dc.date.issued2018-09-12
dc.identifier.issn1475-2840
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/285361
dc.description.abstractBACKGROUND: Ambiguity exists in relation to the role of physical activity (PA) for cardiovascular disease (CVD) risk reduction. We examined the interplay between PA dimensions and more conventional CVD risk factors to assess which PA dimensions were associated with the first CVD event and whether subgroup differences exist. METHODS: A total of 1449 individuals [median age 65.8 (IQR: 61.2, 70.7) years] with low to high risk of type 2 diabetes and free from CVD from the Danish ADDITION-PRO study were included for survival analysis. PA was measured by individually calibrated heart rate and movement sensing for 7 consecutive days. The associations of different PA dimensions (PA energy expenditure, time spent in light-, moderate- and vigorous intensity PA), sedentary time and other conventional CVD risk factors with the first CVD event were examined by tree-structured survival analysis. Baseline information was linked to data on the first CVD event (ischemic heart disease, ischemic stroke, heart failure, atrial flutter/fibrillation and atherosclerotic disease) and mortality obtained from Danish registers. RESULTS: During a median follow-up time of 5.5 (IQR: 5.1-6.1) years, a total of 201 individuals (13.9%) developed CVD. Overall CVD incidence rate was 2.6/100 person-years. PA energy expenditure above 43 kJ/kg/day was associated with lower rates of CVD events among participants ≤ 70 years and with HbA1c ≤ 5.7% (39 mmol/mol), systolic blood pressure ≤ 156 mmHg and albumin creatinine ratio ≤ 70 (incidence rates 0.0-0.8/100 person-years). CONCLUSIONS: Any type of PA resulting in increased PA energy expenditure may over time be the best prevention strategy to uphold reduced risk of CVD.
dc.description.sponsorshipThe ADDITION-Denmark study was supported by the National Health Services in the counties of Copenhagen, Aarhus, Ringkøbing, Ribe, and Southern Jutland in Denmark; the Danish Council for Strategic Research; the Danish Research Foundation for General Practice; Novo Nordisk Foundation; the Danish Centre for Evaluation and Health Technology Assessment; the Diabetes Fund of the National Board of Health; the Danish Medical Research Council; and the Aarhus University Research Foundation. Additionally, the ADDITION-PRO study was funded by an unrestricted grant from the European Foundation for the Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes (74550801), the Danish Council for Strategic Research, and internal research and equipment funds from Steno Diabetes Center.
dc.format.mediumElectronic
dc.languageeng
dc.publisherSpringer Science and Business Media LLC
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectHumans
dc.subjectCardiovascular Diseases
dc.subjectPrognosis
dc.subjectExercise
dc.subjectRisk Assessment
dc.subjectRisk Factors
dc.subjectProspective Studies
dc.subjectRisk Reduction Behavior
dc.subjectTime Factors
dc.subjectAged
dc.subjectMiddle Aged
dc.subjectDenmark
dc.subjectFemale
dc.subjectMale
dc.subjectProtective Factors
dc.subjectHealthy Lifestyle
dc.subjectSedentary Behavior
dc.titleThe role of physical activity in the development of first cardiovascular disease event: a tree-structured survival analysis of the Danish ADDITION-PRO cohort.
dc.typeArticle
prism.issueIdentifier1
prism.publicationDate2018
prism.publicationNameCardiovasc Diabetol
prism.startingPage126
prism.volume17
dc.identifier.doi10.17863/CAM.32728
dcterms.dateAccepted2018-09-04
rioxxterms.versionofrecord10.1186/s12933-018-0769-x
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2018-09-12
dc.contributor.orcidAmadid, Hanan [0000-0001-5759-4960]
dc.contributor.orcidBrage, Soren [0000-0002-1265-7355]
dc.identifier.eissn1475-2840
rioxxterms.typeJournal Article/Review
pubs.funder-project-idMedical Research Council (MC_UU_12015/3)
cam.issuedOnline2018-09-12


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International